01.12.21

Notal Vision Launches First US Home OCT Longitudinal Study with Patient Self-Operated Device

Source: Notal Vision

01.12.21

Clearside Biomedical Announces First Patients Enrolled in Phase 1/2a Clinical Trial of CLS-AX for the Treatment of Wet AMD

Source: Clearside Biomedical

01.08.21

Graybug Vision Completes Treatment Phase of ALTISSIMO Trial in Wet AMD with 12-Month Topline Data

Source: Graybug Vision

12.29.20

Fewer New Cases of Intraocular Inflammation After First Year of Abicipar in AMD Patients

Source: Medscape

12.23.20

Conbercept Treatment of Wet AMD Completes 36-Week Primary Endpoint Visits of Phase 3 Trial

Source: Chengdu Kanghong

12.08.20

RetinAI Announces Collaboration with Novartis to Provide Artificial Intelligence Solutions in Ophthalmology

Source: RetinAI Medical

11.16.20

Innovent Announces the Results of the Phase 1 Clinical Trial of IBI302 for Wet AMD at AAO 2020

Source: Innovent Biologics

11.16.20

Kodiak Sciences Completes Enrollment of Phase 2b/3 Pivotal Study of KSI-301 in Patients with Wet AMD

Source: Kodiak Sciences

11.16.20

Adverum Biotechnologies Announces Positive Interim Data From OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD

Source: Adverum Biotechnologies

11.11.20

Samsung Bioepis Announces 1-year Results From Phase 3 Study of SB11 Proposed Lucentis Biosimilar

Source: Samsung Bioepis

View more stories